These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22076440)

  • 1. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
    Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L
    Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells.
    Kyratzi E; Pavlaki M; Stefanis L
    Hum Mol Genet; 2008 Jul; 17(14):2160-71. PubMed ID: 18411255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
    Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
    Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
    J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.
    Benskey M; Behrouz B; Sunryd J; Pappas SS; Baek SH; Huebner M; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2012 Jun; 33(3):321-31. PubMed ID: 22342763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population.
    Xue S; Jia J
    Brain Res; 2006 May; 1087(1):28-32. PubMed ID: 16626667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Backbone and side-chain 1H, 15N and 13C resonance assignments of S18Y mutant of ubiquitin carboxy-terminal hydrolase L1.
    Tse HS; Hu HY; Sze KH
    Biomol NMR Assign; 2011 Oct; 5(2):165-8. PubMed ID: 21298373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H; Underwood R; Lavalley N; Yacoubian TA
    Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
    Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
    Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.
    Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D
    Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy.
    Kabuta T; Wada K
    Autophagy; 2008 Aug; 4(6):827-9. PubMed ID: 18635949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting UCH in Drosophila melanogaster as a model for Parkinson's disease.
    Thao DTP
    Front Biosci (Landmark Ed); 2020 Jan; 25(1):159-167. PubMed ID: 31585883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
    Lee Y; Heo G; Lee KM; Kim AH; Chung KW; Im E; Chung HY; Lee J
    Brain Res; 2017 May; 1663():184-193. PubMed ID: 28322751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.
    Mellick GD; Silburn PA
    Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.